{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:21:45Z","timestamp":1778509305873,"version":"3.51.4"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Centre, Poland","award":["2018\/31\/B\/NZ5\/00038"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/00038"]}]},{"name":"National Science Centre, Poland","award":["2018\/31\/B\/NZ5\/00038"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/00038"]}]},{"name":"National Science Centre, Poland","award":["2018\/31\/B\/NZ5\/00038"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/00038"]}]},{"name":"National Science Centre, Poland","award":["2018\/31\/B\/NZ5\/00038"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/00038"]}]},{"name":"National Science Centre, Poland","award":["2018\/31\/B\/NZ5\/00038"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/00038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10530-1","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:13:17Z","timestamp":1748826797000},"page":"1061-1074","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urea, TMAO, betaine and other osmolytes as endogenous diuretics in heart failure and hypertension"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-8375","authenticated-orcid":false,"given":"Izabella","family":"Mogilnicka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-5306","authenticated-orcid":false,"given":"Wojciech","family":"Kopacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinga","family":"Jaworska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Alramadhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-8284","authenticated-orcid":false,"given":"Marcin","family":"Ufnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"3","key":"10530_CR1","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ehf2.12677","volume":"7","author":"E Wierda","year":"2020","unstructured":"Wierda E, Dickhoff C, Handoko ML, Oosterom L, Kok WE, de Rover Y et al (2020) Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature. ESC Heart Fail 7(3):892\u2013902","journal-title":"ESC Heart Fail"},{"issue":"12","key":"10530_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63(12):1123\u20131133","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10530_CR3","doi-asserted-by":"publisher","first-page":"e318","DOI":"10.1016\/S2214-109X(20)30028-0","volume":"8","author":"N Naik","year":"2020","unstructured":"Naik N, Narula J (2020) Heart failure in low-income and middle-income countries: failing REPORT card grades. Lancet Glob Health 8(3):e318","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10530_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.111.062430","volume":"126","author":"D Gupta","year":"2012","unstructured":"Gupta D, Georgiopoulou VV, Kalogeropoulos AP, Dunbar SB, Reilly CM, Sands JM et al (2012) Dietary sodium intake in heart failure. Circulation 126(4):479\u2013485","journal-title":"Circulation"},{"issue":"2","key":"10530_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s11936-013-0286-x","volume":"16","author":"MC Konerman","year":"2014","unstructured":"Konerman MC, Hummel SL (2014) Sodium restriction in heart failure: benefit or harm? Curr Treat Options Cardiovasc Med 16(2):286","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"17","key":"10530_CR6","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263\u2013e421","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10530_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archinte.1925.00120160088004","volume":"36","author":"H Crawford","year":"1925","unstructured":"Crawford H, McIntosh JF (1925) The use of urea as a diuretic in advanced heart failure. Arch Intern Med 36(4):530\u2013541","journal-title":"Arch Intern Med"},{"issue":"27","key":"10530_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200","journal-title":"Eur Heart J"},{"issue":"36","key":"10530_CR9","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 42(36):3599\u20133726","journal-title":"Eur Heart J"},{"issue":"37","key":"10530_CR10","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 44(37):3627\u20133639","journal-title":"Eur Heart J"},{"issue":"2","key":"10530_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola V-P, Mebazaa A, Brunner-La Rocca H-P, Martens P et al (2019) The use of diuretics in heart failure with congestion \u2014 a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(2):137\u2013155","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10530_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","volume":"75","author":"GM Felker","year":"2020","unstructured":"Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM (2020) Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol 75(10):1178\u20131195","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10530_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","volume":"82","author":"R Faris","year":"2002","unstructured":"Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A (2002) Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 82(2):149\u2013158","journal-title":"Int J Cardiol"},{"key":"10530_CR14","first-page":"Cd003838","volume":"2","author":"RF Faris","year":"2012","unstructured":"Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ (2012) Diuretics for heart failure. Cochrane Database Syst Rev 2:Cd003838","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10530_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","volume":"82","author":"R Faris","year":"2002","unstructured":"Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A (2002) Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 82(2):149\u2013158","journal-title":"Int J Cardiol"},{"issue":"9","key":"10530_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00392-020-01633-w","volume":"109","author":"J Wintrich","year":"2020","unstructured":"Wintrich J, Kindermann I, Ukena C, Selejan S, Werner C, Maack C et al (2020) Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future. Clin Res Cardiol 109(9):1079\u20131098","journal-title":"Clin Res Cardiol"},{"issue":"15","key":"10530_CR17","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","volume":"74","author":"SM Hollenberg","year":"2019","unstructured":"Hollenberg SM, Warner Stevenson L, Ahmad T, Amin VJ, Bozkurt B, Butler J et al (2019) 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure. A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 74(15):1966\u20132011","journal-title":"J Am Coll Cardiol"},{"key":"10530_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11739-018-02019-7","volume":"14","author":"J-C Trull\u00e0s","year":"2019","unstructured":"Trull\u00e0s J-C, Casado J, Morales-Rull J-L, Formiga F, Conde-Martel A, Quir\u00f3s R et al (2019) Prevalence and outcome of diuretic resistance in heart failure. Intern Emerg Med 14:529\u2013537","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10530_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","volume":"12","author":"JM ter Maaten","year":"2015","unstructured":"ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA (2015) Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol 12(3):184\u2013192","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"10530_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1753944717718717","volume":"11","author":"N Shah","year":"2017","unstructured":"Shah N, Madanieh R, Alkan M, Dogar MU, Kosmas CE, Vittorio TJ (2017) A perspective on diuretic resistance in chronic congestive heart failure. Ther Adv Cardiovasc Dis 11(10):271\u2013278","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"2","key":"10530_CR21","first-page":"e6952","volume":"12","author":"MR Zafar","year":"2020","unstructured":"Zafar MR, Miller TW, Mustafa SF, Al-Khafaji N (2020) Pharmacological and non-pharmacological strategies for volume overload in acute decompensated congestive heart failure: a review article. Cureus 12(2):e6952","journal-title":"Cureus"},{"issue":"10","key":"10530_CR22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.7326\/0003-4819-114-10-886","volume":"114","author":"DH Ellison","year":"1991","unstructured":"Ellison DH (1991) The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 114(10):886\u2013894","journal-title":"Ann Intern Med"},{"issue":"8","key":"10530_CR23","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.cardfail.2013.06.159","volume":"19","author":"KT Kissling","year":"2013","unstructured":"Kissling KT, Pickworth KK (2013) Synergistic blockade for diuretic resistance in heart failure: comparable outcomes with oral hydrochlorothiazide or intravenous chlorothiazide. J Card Fail 19(8):S49","journal-title":"J Card Fail"},{"issue":"19","key":"10530_CR24","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","volume":"56","author":"JC Jentzer","year":"2010","unstructured":"Jentzer JC, DeWald TA, Hernandez AF (2010) Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 56(19):1527\u20131534","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10530_CR25","first-page":"581","volume":"19","author":"DH Ellison","year":"1999","unstructured":"Ellison DH (1999) Diuretic resistance: physiology and therapeutics. Semin Nephrol 19(6):581\u2013597","journal-title":"Semin Nephrol"},{"issue":"10","key":"10530_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1753944717718717","volume":"11","author":"N Shah","year":"2017","unstructured":"Shah N, Madanieh R, Alkan M, Dogar MU, Kosmas CE, Vittorio TJ (2017) A perspective on diuretic resistance in chronic congestive heart failure. Ther Adv Cardiovasc Dis 11(10):271\u2013278","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"31","key":"10530_CR27","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1093\/eurheartj\/ehad283","volume":"44","author":"S Chatur","year":"2023","unstructured":"Chatur S, Vaduganathan M, Claggett B, Vardeny O, Desai AS, Jhund PS et al (2023) Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. Eur Heart J 44(31):2930\u20132943","journal-title":"Eur Heart J"},{"issue":"2","key":"10530_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14740\/cr1627","volume":"15","author":"CA Umeh","year":"2024","unstructured":"Umeh CA, Mohta T, Kaur G, Truong R, Darji P, Vue C et al (2024) Acetazolamide and hydrochlorothiazide in patients with acute decompensated heart failure: insights from recent trials. Cardiol Res 15(2):69\u201374","journal-title":"Cardiol Res"},{"issue":"5","key":"10530_CR29","first-page":"e006597","volume":"13","author":"JP Ferreira","year":"2020","unstructured":"Ferreira JP, Eschalier R, Duarte K, Damman K, Gustafsson F, Schou M et al (2020) Reduced diuretic dose in patients treated with eplerenone. Circulation: Heart Fail 13(5):e006597","journal-title":"Circulation: Heart Fail"},{"issue":"1","key":"10530_CR30","doi-asserted-by":"publisher","first-page":"e002370","DOI":"10.1161\/CIRCHEARTFAILURE.115.002370","volume":"9","author":"JM Testani","year":"2016","unstructured":"Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O et al (2016) Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure. Circ Heart Fail 9(1):e002370","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10530_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","volume":"16","author":"R Gupta","year":"2019","unstructured":"Gupta R, Testani J, Collins S (2019) Diuretic resistance in heart failure. Curr Heart Fail Rep 16(2):57\u201366","journal-title":"Curr Heart Fail Rep"},{"issue":"4","key":"10530_CR32","first-page":"315","volume":"14","author":"RH Schwinger","year":"1992","unstructured":"Schwinger RH, Erdmann E (1992) Heart failure and electrolyte disturbances. Methods Find Exp Clin Pharmacol 14(4):315\u2013325","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"10530_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.15420\/ecr.2015.10.01.42","volume":"10","author":"G Casu","year":"2015","unstructured":"Casu G, Merella P (2015) Diuretic therapy in heart failure - current approaches. Eur Cardiol 10(1):42\u201347","journal-title":"Eur Cardiol"},{"issue":"5","key":"10530_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2217\/fca.15.53","volume":"11","author":"S Emani","year":"2015","unstructured":"Emani S, Meyer M, Palm D, Holzmeister J, Haas GJ (2015) Ularitide: a natriuretic peptide candidate for the treatment of acutely decompensated heart failure. Future Cardiol 11(5):531\u2013546","journal-title":"Future Cardiol"},{"issue":"2","key":"10530_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0025-7125(02)00181-5","volume":"87","author":"LC Costello-Boerrigter","year":"2003","unstructured":"Costello-Boerrigter LC, Boerrigter G, Burnett JC Jr (2003) Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics. Med Clin North Am 87(2):475\u2013491","journal-title":"Med Clin North Am"},{"key":"10530_CR36","unstructured":"Whelton PK, Carey RM, Aronow WS. Acc\/aha\/aapa\/abc\/acpm\/ags\/APhA\/ASH\/ASPC\/nma\/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American heart Association. Task force on clinical practice guidelines\/\/J. Am. Coll. Cardiol.-2017.-Nov 13. \u041fo\u0447\u043a\u0438. 2018;7(1):68\u201374."},{"key":"10530_CR37","doi-asserted-by":"publisher","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, Hanssen H, Harris J, Lauder L, McManus RJ, Molloy GJ, Rahimi K, Regitz-Zagrosek V, Rossi GP, Sandset EC, Scheenaerts B, Staessen JA, Uchmanowicz I, Volterrani M, Touyz RM (2024) ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178. Erratum in: Eur Heart J 2025 Apr 7;46(14):1300. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf031","DOI":"10.1093\/eurheartj\/ehae178"},{"issue":"5","key":"10530_CR38","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR et al (2018) Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension 72(5):e53\u2013e90","journal-title":"Hypertension"},{"key":"10530_CR39","doi-asserted-by":"publisher","unstructured":"Starling EH (1896) On the absorption of fluids from the connective tissue spaces. J Physiol 19(4):312\u201326. https:\/\/doi.org\/10.1113\/jphysiol.1896.sp000596","DOI":"10.1113\/jphysiol.1896.sp000596"},{"issue":"3","key":"10530_CR40","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1152\/physrev.00037.2011","volume":"92","author":"H Wiig","year":"2012","unstructured":"Wiig H, Swartz MA (2012) Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 92(3):1005\u20131060","journal-title":"Physiol Rev"},{"issue":"3","key":"10530_CR41","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1152\/physrev.00037.2011","volume":"92","author":"H Wiig","year":"2012","unstructured":"Wiig H, Swartz MA (2012) Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 92(3):1005\u20131060","journal-title":"Physiol Rev"},{"issue":"14","key":"10530_CR42","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","volume":"118","author":"MR Zile","year":"2008","unstructured":"Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF et al (2008) Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118(14):1433\u201341","journal-title":"Circulation"},{"issue":"11","key":"10530_CR43","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","volume":"34","author":"AP Ambrosy","year":"2013","unstructured":"Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B et al (2013) Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial \u2020. Eur Heart J 34(11):835\u2013843","journal-title":"Eur Heart J"},{"issue":"6","key":"10530_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","volume":"62","author":"FH Verbrugge","year":"2013","unstructured":"Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH et al (2013) Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol 62(6):485\u2013495","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10530_CR45","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","volume":"50","author":"A Sandek","year":"2007","unstructured":"Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S et al (2007) Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50(16):1561\u20131569","journal-title":"J Am Coll Cardiol"},{"key":"10530_CR46","doi-asserted-by":"publisher","unstructured":"Judy E, Kishore N (2016) Biological wonders of osmolytes: the need to know more. Biochem Anal Biochem 5: 304. https:\/\/doi.org\/10.4172\/2161-1009.1000304","DOI":"10.4172\/2161-1009.1000304"},{"issue":"177","key":"10530_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.24976\/Discov.Med.202335177.50","volume":"35","author":"L Tomasova","year":"2023","unstructured":"Tomasova L, Maksymiuk K, Chabowski D, Samborowska E, Ufnal M (2023) Mice, rats and guinea pigs exhibit significant variations in the plasma, urine and tissue levels of taurine, betaine, sarcosine and other osmolyte-active amino acids. Discov Med 35(177):492\u2013502","journal-title":"Discov Med"},{"issue":"1 Pt 2","key":"10530_CR48","first-page":"F230","volume":"271","author":"ED Kwon","year":"1996","unstructured":"Kwon ED, Dooley JA, Jung KY, Andrews PM, Garc\u00eda-P\u00e9rez A, Burg MB (1996) Organic osmolyte distribution and levels in the mammalian urinary bladder in diuresis and antidiuresis. Am J Physiol 271(1 Pt 2):F230\u2013F233","journal-title":"Am J Physiol"},{"issue":"6","key":"10530_CR49","doi-asserted-by":"publisher","first-page":"C1417","DOI":"10.1152\/ajpcell.00468.2003","volume":"286","author":"SF Tomassen","year":"2004","unstructured":"Tomassen SF, Fekkes D, De Jonge HR, Tilly BC (2004) Osmotic swelling-provoked release of organic osmolytes in human intestinal epithelial cells. Am J Physiol Cell Physiol 286(6):C1417\u2013C1422","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10530_CR50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/hep.510270235","volume":"27","author":"C Weik","year":"1998","unstructured":"Weik C, Warskulat U, Bode J, Peters-Regehr T, H\u00e4ussinger D (1998) Compatible organic osmolytes in rat liver sinusoidal endothelial cells. Hepatology 27(2):569\u2013575","journal-title":"Hepatology"},{"issue":"6","key":"10530_CR51","first-page":"499","volume":"34","author":"M Schmolke","year":"1996","unstructured":"Schmolke M, Schilling A, Keiditsch E, Guder WG (1996) Intrarenal distribution of organic osmolytes in human kidney. Eur J Clin Chem Clin Biochem 34(6):499\u2013501","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10530_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.physiol.67.031103.154456","volume":"67","author":"W Neuhofer","year":"2005","unstructured":"Neuhofer W, Beck FX (2005) Cell survival in the hostile environment of the renal medulla. Annu Rev Physiol 67:531\u2013555","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"10530_CR53","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1152\/physrev.00056.2006","volume":"87","author":"MB Burg","year":"2007","unstructured":"Burg MB, Ferraris JD, Dmitrieva NI (2007) Cellular response to hyperosmotic stresses. Physiol Rev 87(4):1441\u20131474","journal-title":"Physiol Rev"},{"issue":"12","key":"10530_CR54","doi-asserted-by":"publisher","first-page":"7309","DOI":"10.1074\/jbc.R700042200","volume":"283","author":"MB Burg","year":"2008","unstructured":"Burg MB, Ferraris JD (2008) Intracellular organic osmolytes: function and regulation. J Biol Chem 283(12):7309\u20137313","journal-title":"J Biol Chem"},{"issue":"12","key":"10530_CR55","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/iub.406","volume":"62","author":"SH Khan","year":"2010","unstructured":"Khan SH, Ahmad N, Ahmad F, Kumar R (2010) Naturally occurring organic osmolytes: from cell physiology to disease prevention. IUBMB Life 62(12):891\u2013895","journal-title":"IUBMB Life"},{"issue":"Pt B","key":"10530_CR56","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.ijbiomac.2017.10.021","volume":"107","author":"MA Dar","year":"2018","unstructured":"Dar MA, Wahiduzzaman, Islam A, Hassan MI, Ahmad F (2018) Counteraction of the deleterious effects of urea on structure and stability of mammalian kidney proteins by osmolytes. Int J Biol Macromol 107(Pt B):1659\u201367","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10530_CR57","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-physiol-021113-170350","volume":"76","author":"JM Sands","year":"2014","unstructured":"Sands JM, Layton HE (2014) Advances in understanding the urine-concentrating mechanism. Annu Rev Physiol 76(1):387\u2013409","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10530_CR58","doi-asserted-by":"publisher","first-page":"F188","DOI":"10.1152\/ajprenal.00200.2004","volume":"288","author":"D Kim","year":"2005","unstructured":"Kim D, Klein JD, Racine S, Murrell BP, Sands JM (2005) Urea may regulate urea transporter protein abundance during osmotic diuresis. Am J Physiol Renal Physiol 288(1):F188\u2013F197","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10530_CR59","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1152\/ajplegacy.1949.158.2.218","volume":"158","author":"GH Mudge","year":"1949","unstructured":"Mudge GH, Foulks J, Gilman A (1949) Effect of urea diuresis on renal excretion of electrolytes. Am J Physiol-Legacy Content 158(2):218\u2013230","journal-title":"Am J Physiol-Legacy Content"},{"issue":"6","key":"10530_CR60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1440-1681.1984.tb00867.x","volume":"11","author":"H Wang","year":"1984","unstructured":"Wang H, Ikeda K, Kihara M, Nara Y, Horie R, Yamori Y (1984) Effect of dietary urea on blood pressure in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 11(6):555\u2013561","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10530_CR61","first-page":"233","volume":"6","author":"MA Brisco","year":"2013","unstructured":"Brisco MA, Coca SG, Chen J, Owens AT, McCauley BD, Kimmel SE et al (2013) Blood urea nitrogen\/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circulation: Heart Fail 6(2):233\u20139","journal-title":"Circulation: Heart Fail"},{"key":"10530_CR62","unstructured":"Jujo K, Tanigaito Y, Minami Y, Yoshida A, Kikuchi Y, Haruki S, et al. Abstract 18113: persistent high blood urea nitrogen level is associated with increased cardiovascular mortality in acute heart failure patients. Circulation. 2016;134(suppl_1):A18113-A."},{"issue":"1","key":"10530_CR63","doi-asserted-by":"publisher","first-page":"13507","DOI":"10.1038\/s41598-018-31059-4","volume":"8","author":"X Ren","year":"2018","unstructured":"Ren X, Qu W, Zhang L, Liu M, Gao X, Gao Y et al (2018) Role of blood urea nitrogen in predicting the post-discharge prognosis in elderly patients with acute decompensated heart failure. Sci Rep 8(1):13507","journal-title":"Sci Rep"},{"issue":"4","key":"10530_CR64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/MD.0b013e3181e893ee","volume":"89","author":"I Gotsman","year":"2010","unstructured":"Gotsman I, Zwas D, Planer D, Admon D, Lotan C, Keren A (2010) The significance of serum urea and renal function in patients with heart failure. Medicine 89(4):197\u2013203","journal-title":"Medicine"},{"issue":"2","key":"10530_CR65","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/BF00831001","volume":"89","author":"SI Pisarenko","year":"1980","unstructured":"Pisarenko SI, Minkovskii EB, Studneva IM (1980) Urea synthesis in heart muscle. Bull Exp Biol Med 89(2):138\u2013141","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"10530_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/hh1401.093293","volume":"89","author":"R Duchesne","year":"2001","unstructured":"Duchesne R, Klein JD, Velotta JB, Doran JJ, Rouillard P, Roberts BR et al (2001) UT-A urea transporter protein in heart: increased abundance during uremia, hypertension, and heart failure. Circ Res 89(2):139\u2013145","journal-title":"Circ Res"},{"issue":"10","key":"10530_CR67","doi-asserted-by":"publisher","first-page":"e2340313","DOI":"10.1001\/jamanetworkopen.2023.40313","volume":"6","author":"R Wendt","year":"2023","unstructured":"Wendt R, Fenves AZ, Geisler BP (2023) Use of urea for the syndrome of inappropriate secretion of antidiuretic hormone: a systematic review. JAMA Netw Open 6(10):e2340313","journal-title":"JAMA Netw Open"},{"issue":"1\u20132","key":"10530_CR68","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000503773","volume":"49","author":"H Rondon-Berrios","year":"2020","unstructured":"Rondon-Berrios H (2020) Urea for chronic hyponatremia. Blood Purif 49(1\u20132):212\u2013218","journal-title":"Blood Purif"},{"issue":"1","key":"10530_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/17446651.2019.1556095","volume":"14","author":"A Peri","year":"2019","unstructured":"Peri A (2019) Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment. Expert Rev Endocrinol Metab 14(1):13\u201321","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"10530_CR70","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1038\/s41598-022-14387-4","volume":"12","author":"E Perell\u00f3-Camacho","year":"2022","unstructured":"Perell\u00f3-Camacho E, Pomares-G\u00f3mez FJ, L\u00f3pez-Penabad L, Mirete-L\u00f3pez RM, Pinedo-Esteban MR, Dom\u00ednguez-Escribano JR (2022) Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion. Sci Rep 12(1):10266","journal-title":"Sci Rep"},{"issue":"3","key":"10530_CR71","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/00185787211037548","volume":"57","author":"WM Hammonds","year":"2022","unstructured":"Hammonds WM, Keating EA, Smetana ME, Smetana KS, Bond MM (2022) Safety and efficacy of urea for hyponatremia. Hosp Pharm 57(3):365\u2013369","journal-title":"Hosp Pharm"},{"issue":"6299","key":"10530_CR72","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/bmj.283.6299.1081","volume":"283","author":"G Decaux","year":"1981","unstructured":"Decaux G, Genette F (1981) Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone. Br Med J (Clin Res Ed) 283(6299):1081\u20131083","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"10530_CR73","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/ANA.0000000000000340","volume":"29","author":"F Annoni","year":"2017","unstructured":"Annoni F, Fontana V, Brimioulle S, Creteur J, Vincent J-L, Taccone FS (2017) Early effects of enteral urea on intracranial pressure in patients with acute brain injury and hyponatremia. J Neurosurg Anesthesiol 29(4):400\u2013405","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"10530_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms25010003","volume":"25","author":"H Rashid","year":"2024","unstructured":"Rashid H, Jali A, Akhter MS, Abdi SAH (2024) Molecular mechanisms of oxidative stress in acute kidney injury: targeting the loci by resveratrol. Int J Mol Sci 25(1):3","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10530_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI37672","volume":"120","author":"M D\u2019Apolito","year":"2010","unstructured":"D\u2019Apolito M, Du X, Zong H, Catucci A, Maiuri L, Trivisano T et al (2010) Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Investig 120(1):203\u2013213","journal-title":"J Clin Investig"},{"issue":"9","key":"10530_CR76","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1172\/JCI86181","volume":"126","author":"L Koppe","year":"2016","unstructured":"Koppe L, Nyam E, Vivot K, Fox JEM, Dai X-Q, Nguyen BN et al (2016) Urea impairs \u03b2 cell glycolysis and insulin secretion in chronic kidney disease. J Clin Investig 126(9):3598\u20133612","journal-title":"J Clin Investig"},{"issue":"suppl_3","key":"10530_CR77","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","volume":"33","author":"G Cobo","year":"2018","unstructured":"Cobo G, Lindholm B, Stenvinkel P (2018) Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant 33(suppl_3):iii35\u2013iii40","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10530_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","volume":"37","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Yuan J, Norris K (2013) Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol 37(1):1\u20136","journal-title":"Am J Nephrol"},{"key":"10530_CR79","unstructured":"Olano CG, Akram SM, Hashmi MF, Bhatt H (2024) Uremic Encephalopathy. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL)"},{"issue":"5","key":"10530_CR80","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1172\/JCI103855","volume":"38","author":"EF Grollman","year":"1959","unstructured":"Grollman EF, Grollman A (1959) Toxicity of urea and its role in the pathogenesis of uremia. J Clin Investig 38(5):749\u2013754","journal-title":"J Clin Investig"},{"key":"10530_CR81","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4899-0117-0_27","volume-title":"Taurine 3: Cellular and Regulatory Mechanisms","author":"H Pasantes-Morales","year":"1998","unstructured":"Pasantes-Morales H, Quesada O, Mor\u00e1n J (1998) Taurine: An osmolyte in mammalian tissues. In: Schaffer S, Lombardini JB, Huxtable RJ (eds) Taurine 3: Cellular and Regulatory Mechanisms. Springer, US, Boston, MA, pp 209\u2013217"},{"issue":"1","key":"10530_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s004240000506","volume":"442","author":"M Bitoun","year":"2001","unstructured":"Bitoun M, Levillain O, Tappaz M (2001) Gene expression of the taurine transporter and taurine biosynthetic enzymes in rat kidney after antidiuresis and salt loading. Pflugers Arch 442(1):87\u201395","journal-title":"Pflugers Arch"},{"issue":"1","key":"10530_CR83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00726-006-0363-5","volume":"31","author":"A Riesenhuber","year":"2006","unstructured":"Riesenhuber A, Boehm M, Posch M, Aufricht C (2006) Diuretic potential of energy drinks. Amino Acids 31(1):81\u201383","journal-title":"Amino Acids"},{"issue":"5","key":"10530_CR84","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0006-2952(97)00213-X","volume":"54","author":"MS Mozaffari","year":"1997","unstructured":"Mozaffari MS, Azuma J, Patel C, Schaffer SW (1997) Renal excretory responses to saline load in the taurine-depleted and the taurine-supplemented rat. Biochem Pharmacol 54(5):619\u2013624","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10530_CR85","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1046\/j.1523-1755.2002.00317.x","volume":"61","author":"MS Mozaffari","year":"2002","unstructured":"Mozaffari MS, Schaffer SW (2002) Chronic taurine treatment ameliorates reduction in saline-induced diuresis and natriuresis. Kidney Int 61(5):1750\u20131759","journal-title":"Kidney Int"},{"key":"10530_CR86","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/978-1-4615-9543-4_98","volume-title":"Kinins V","author":"M Horiuchi","year":"1989","unstructured":"Horiuchi M, Kohashi N, Nishiyama H, Takenaka T, Kondo H, Katori R et al (1989) Attenuation of atrial natriuretic peptide by Kallikrein in taurine administered rats. In: Abe K, Moriya H, Fujii S (eds) Kinins V. Springer US, Boston, pp 629\u201334"},{"issue":"3\u20134","key":"10530_CR87","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s007260070014","volume":"19","author":"R Dawson Jr","year":"2000","unstructured":"Dawson R Jr, Liu S, Jung B, Messina S, Eppler B (2000) Effects of high salt diets and taurine on the development of hypertension in the stroke-prone spontaneously hypertensive rat. Amino Acids 19(3\u20134):643\u2013665","journal-title":"Amino Acids"},{"issue":"21","key":"10530_CR88","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/0024-3205(94)90030-2","volume":"54","author":"S Gentile","year":"1994","unstructured":"Gentile S, Bologna E, Terracina D, Angelico M (1994) Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. Life Sci 54(21):1585\u20131593","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"10530_CR89","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1423-0127-17-S1-S6","volume":"17 Suppl 1","author":"Y Yamori","year":"2010","unstructured":"Yamori Y, Taguchi T, Hamada A, Kunimasa K, Mori H, Mori M (2010) Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. J Biomed Sci 17 Suppl 1(Suppl 1):S6","journal-title":"J Biomed Sci"},{"issue":"5","key":"10530_CR90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/clc.4960080507","volume":"8","author":"J Azuma","year":"1985","unstructured":"Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H et al (1985) Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 8(5):276\u2013282","journal-title":"Clin Cardiol"},{"issue":"3","key":"10530_CR91","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jjcc.2011.01.007","volume":"57","author":"MR Beyranvand","year":"2011","unstructured":"Beyranvand MR, Kadkhodai Khalafi M, Roshan VD, Choobineh S, Parsa SA, Piranfar MA (2011) Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol 57(3):333\u2013337","journal-title":"J Cardiol"},{"issue":"4","key":"10530_CR92","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1080\/19390211.2016.1267059","volume":"14","author":"M Ahmadian","year":"2017","unstructured":"Ahmadian M, Dabidi Roshan V, Ashourpore E (2017) Taurine supplementation improves functional capacity, myocardial oxygen consumption, and electrical activity in heart failure. Journal of Dietary Supplements 14(4):422\u2013432","journal-title":"Journal of Dietary Supplements"},{"key":"10530_CR93","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12688\/wellcomeopenres.17505.2","volume":"7","author":"KA McGurk","year":"2022","unstructured":"McGurk KA, Kasapi M, Ware JS (2022) Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review. Wellcome Open Res 7:9","journal-title":"Wellcome Open Res"},{"issue":"4","key":"10530_CR94","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00726-002-0212-0","volume":"23","author":"JD Militante","year":"2002","unstructured":"Militante JD, Lombardini JB (2002) Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23(4):381\u2013393","journal-title":"Amino Acids"},{"key":"10530_CR95","first-page":"2673","volume":"18","author":"H Ripps","year":"2012","unstructured":"Ripps H, Shen W (2012) Review: taurine: a \u201cvery essential\u201d amino acid. Mol Vis 18:2673\u20132686","journal-title":"Mol Vis"},{"issue":"3","key":"10530_CR96","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1161\/HYPERTENSIONAHA.115.06624","volume":"67","author":"Q Sun","year":"2016","unstructured":"Sun Q, Wang B, Li Y, Sun F, Li P, Xia W et al (2016) Taurine supplementation lowers blood pressure and improves vascular function in prehypertension. Hypertension 67(3):541\u2013549","journal-title":"Hypertension"},{"issue":"9","key":"10530_CR97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11906-018-0881-z","volume":"20","author":"M Waldron","year":"2018","unstructured":"Waldron M, Patterson SD, Tallent J, Jeffries O (2018) The effects of oral taurine on resting blood pressure in humans: a meta-analysis. Curr Hypertens Rep 20(9):81","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10530_CR98","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00380-003-0757-1","volume":"19","author":"H Harada","year":"2004","unstructured":"Harada H, Tsujino T, Watari Y, Nonaka H, Emoto N, Yokoyama M (2004) Oral taurine supplementation prevents fructose-induced hypertension in rats. Heart Vessels 19(3):132\u2013136","journal-title":"Heart Vessels"},{"issue":"8","key":"10530_CR99","doi-asserted-by":"publisher","first-page":"e105851","DOI":"10.1371\/journal.pone.0105851","volume":"9","author":"AR Maia","year":"2014","unstructured":"Maia AR, Batista TM, Victorio JA, Clerici SP, Delbin MA, Carneiro EM et al (2014) Taurine supplementation reduces blood pressure and prevents endothelial dysfunction and oxidative stress in post-weaning protein-restricted rats. PLoS ONE 9(8):e105851","journal-title":"PLoS ONE"},{"issue":"3","key":"10530_CR100","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1440-1681.2006.04345.x","volume":"33","author":"HH Hagar","year":"2006","unstructured":"Hagar HH, El Etter E, Arafa M (2006) Taurine attenuates hypertension and renal dysfunction induced by cyclosporine a in rats. Clin Exp Pharmacol Physiol 33(3):189\u2013196","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"10530_CR101","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/ajh.2011.4","volume":"24","author":"MM Rahman","year":"2011","unstructured":"Rahman MM, Park H-M, Kim S-J, Go H-K, Kim G-B, Hong C-U et al (2011) Taurine prevents hypertension and increases exercise capacity in rats with fructose-induced hypertension. Am J Hypertens 24(5):574\u2013581","journal-title":"Am J Hypertens"},{"issue":"9","key":"10530_CR102","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11906-018-0881-z","volume":"20","author":"M Waldron","year":"2018","unstructured":"Waldron M, Patterson SD, Tallent J, Jeffries O (2018) The effects of oral taurine on resting blood pressure in humans: a meta-analysis. Curr Hypertens Rep 20(9):81","journal-title":"Curr Hypertens Rep"},{"key":"10530_CR103","doi-asserted-by":"publisher","unstructured":"Cho CE, Taesuwan S, Malysheva OV, Bender E, Tulchinsky NF, Yan J, Sutter JL, Caudill MA (2017) Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res 61(1). https:\/\/doi.org\/10.1002\/mnfr.201600324","DOI":"10.1002\/mnfr.201600324"},{"key":"10530_CR104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jnutbio.2017.02.010","volume":"45","author":"S Taesuwan","year":"2017","unstructured":"Taesuwan S, Cho CE, Malysheva OV, Bender E, King JH, Yan J et al (2017) The metabolic fate of isotopically labeled trimethylamine-N-oxide (TMAO) in humans. J Nutr Biochem 45:77\u201382","journal-title":"J Nutr Biochem"},{"issue":"1","key":"10530_CR105","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/jacs.7b11695","volume":"140","author":"P Ganguly","year":"2018","unstructured":"Ganguly P, Boserman P, van der Vegt NFA, Shea J-E (2018) Trimethylamine N-oxide counteracts urea denaturation by inhibiting protein\u2013urea preferential interaction. J Am Chem Soc 140(1):483\u2013492","journal-title":"J Am Chem Soc"},{"key":"10530_CR106","doi-asserted-by":"publisher","first-page":"e57028","DOI":"10.7554\/eLife.57028","volume":"9","author":"M Gawrys-Kopczynska","year":"2020","unstructured":"Gawrys-Kopczynska M, Konop M, Maksymiuk K, Kraszewska K, Derzsi L, Sozanski K et al (2020) TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats. eLife 9:e57028","journal-title":"eLife"},{"key":"10530_CR107","doi-asserted-by":"publisher","first-page":"109271","DOI":"10.1016\/j.mehy.2019.109271","volume":"130","author":"M Ufnal","year":"2019","unstructured":"Ufnal M, Nowi\u0144ski A (2019) Is increased plasma TMAO a compensatory response to hydrostatic and osmotic stress in cardiovascular diseases? Med Hypotheses 130:109271","journal-title":"Med Hypotheses"},{"issue":"9","key":"10530_CR108","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/toxins11090490","volume":"11","author":"K Jaworska","year":"2019","unstructured":"Jaworska K, Hering D, Mosieniak G, Bielak-Zmijewska A, Pilz M, Konwerski M et al (2019) TMA, A forgotten uremic toxin, but not TMAO, is involved in cardiovascular pathology. Toxins 11(9):490","journal-title":"Toxins"},{"issue":"6","key":"10530_CR109","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/joim.12328","volume":"277","author":"M Tr\u00f8seid","year":"2015","unstructured":"Tr\u00f8seid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP et al (2015) Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med 277(6):717\u2013726","journal-title":"J Intern Med"},{"issue":"11","key":"10530_CR110","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/heartjnl-2015-308826","volume":"102","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Heaney LM, Bhandari SS, Jones DJL, Ng LL (2016) Trimethylamine N-oxide and prognosis in acute heart failure. Heart 102(11):841\u2013848","journal-title":"Heart"},{"issue":"18","key":"10530_CR111","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WW Tang","year":"2014","unstructured":"Tang WW, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM et al (2014) Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol 64(18):1908\u20131914","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10530_CR112","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/labmed\/lmaa075","volume":"52","author":"Z Dong","year":"2021","unstructured":"Dong Z, Zheng S, Shen Z, Luo Y, Hai X (2021) Trimethylamine N-oxide is associated with heart failure risk in patients with preserved ejection fraction. Lab Med 52(4):346\u2013351","journal-title":"Lab Med"},{"issue":"11","key":"10530_CR113","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/bcp.13728","volume":"84","author":"G Latkovskis","year":"2018","unstructured":"Latkovskis G, Makarova E, Mazule M, Bondare L, Hartmane D, Cirule H et al (2018) Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide. Br J Clin Pharmacol 84(11):2634\u20132644","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10530_CR114","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacbts.2020.11.010","volume":"6","author":"DY Li","year":"2021","unstructured":"Li DY, Wang Z, Jia X, Yan D, Shih DM, Hazen SL et al (2021) Loop diuretics inhibit renal excretion of trimethylamine N-oxide. JACC Basic Transl Sci 6(2):103\u2013115","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10530_CR115","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12933-022-01505-9","volume":"21","author":"M Wargny","year":"2022","unstructured":"Wargny M, Croyal M, Ragot S, Gand E, Jacobi D, Trochu JN et al (2022) Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort. Cardiovasc Diabetol 21(1):101","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"10530_CR116","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/ejhf.1338","volume":"21","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, Yazaki Y, Voors AA, Jones DJL, Chan DCS, Anker SD et al (2019) Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF. Eur J Heart Fail 21(7):877\u2013886","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10530_CR117","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12933-023-01920-6","volume":"22","author":"F Aziz","year":"2023","unstructured":"Aziz F, Tripolt NJ, Pferschy PN, Kolesnik E, Mangge H, Curcic P et al (2023) Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial. Cardiovasc Diabetol 22(1):184","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10530_CR118","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hfc.2019.08.001","volume":"16","author":"A Salzano","year":"2020","unstructured":"Salzano A, Cassambai S, Yazaki Y, Israr MZ, Bernieh D, Wong M et al (2020) The gut axis involvement in heart failure: focus on trimethylamine N-oxide. Heart Fail Clin 16(1):23\u201331","journal-title":"Heart Fail Clin"},{"issue":"3","key":"10530_CR119","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41374-018-0091-y","volume":"99","author":"Z Li","year":"2019","unstructured":"Li Z, Wu Z, Yan J, Liu H, Liu Q, Deng Y et al (2019) Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis. Lab Invest 99(3):346\u2013357","journal-title":"Lab Invest"},{"issue":"1","key":"10530_CR120","doi-asserted-by":"publisher","first-page":"e002314","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","volume":"9","author":"CL Organ","year":"2016","unstructured":"Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R et al (2016) Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure. Circ Heart Fail 9(1):e002314","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10530_CR121","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3390\/ijms20123045","volume":"20","author":"G Querio","year":"2019","unstructured":"Querio G, Antoniotti S, Levi R, Gallo MP (2019) Trimethylamine N-oxide does not impact viability, ROS production, and mitochondrial membrane potential of adult rat cardiomyocytes. Int J Mol Sci 20(12):3045","journal-title":"Int J Mol Sci"},{"key":"10530_CR122","doi-asserted-by":"publisher","first-page":"622741","DOI":"10.3389\/fcell.2020.622741","volume":"8","author":"M Videja","year":"2020","unstructured":"Videja M, Vilskersts R, Korzh S, Cirule H, Sevostjanovs E, Dambrova M et al (2020) Microbiota-derived metabolite trimethylamine N-oxide protects mitochondrial energy metabolism and cardiac functionality in a rat model of right ventricle heart failure. Front Cell Dev Biol 8:622741","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10530_CR123","doi-asserted-by":"publisher","first-page":"H1805","DOI":"10.1152\/ajpheart.00536.2018","volume":"315","author":"T Huc","year":"2018","unstructured":"Huc T, Drapala A, Gawrys M, Konop M, Bielinska K, Zaorska E et al (2018) Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats. Am J Physiol Heart Circ Physiol 315(6):H1805\u2013H1820","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10530_CR124","first-page":"287","volume":"3","author":"H Brieger","year":"1951","unstructured":"Brieger H, Hodes WA (1951) Toxic effects of exposure to vapors of aliphatic amines. AMA Arch Ind Hyg Occup Med 3(3):287\u2013291","journal-title":"AMA Arch Ind Hyg Occup Med"},{"issue":"7","key":"10530_CR125","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/gerona\/glz181","volume":"75","author":"K Jaworska","year":"2020","unstructured":"Jaworska K, Konop M, Hutsch T, Perlejewski K, Radkowski M, Grochowska M et al (2020) Trimethylamine but not trimethylamine oxide increases with age in rat plasma and affects smooth muscle cells viability. J Gerontol A Biol Sci Med Sci 75(7):1276\u20131283","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"23","key":"10530_CR126","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1073\/pnas.1403224111","volume":"111","author":"J Ma","year":"2014","unstructured":"Ma J, Pazos IM, Gai F (2014) Microscopic insights into the protein-stabilizing effect of trimethylamine N-oxide (TMAO). Proc Natl Acad Sci USA 111(23):8476\u20138481","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10530_CR127","doi-asserted-by":"publisher","first-page":"dmm049975","DOI":"10.1242\/dmm.049975","volume":"16","author":"S Naghipour","year":"2023","unstructured":"Naghipour S, Fisher JJ, Perkins AV, Peart JN, Headrick JP, Toit EFD (2023) A gut microbiome metabolite paradoxically depresses contractile function while activating mitochondrial respiration. Dis Models Mech 16(5):dmm049975","journal-title":"Dis Models Mech"},{"key":"10530_CR128","doi-asserted-by":"publisher","first-page":"622741","DOI":"10.3389\/fcell.2020.622741","volume":"8","author":"M Videja","year":"2021","unstructured":"Videja M, Vilskersts R, Korzh S, Cirule H, Sevostjanovs E, Dambrova M et al (2021) 2020 Microbiota-derived metabolite trimethylamine N-oxide protects mitochondrial energy metabolism and cardiac functionality in a rat model of right ventricle heart failure. Front Cell Dev Biol 8:622741","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10530_CR129","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/advances\/nmz064","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge X, Zheng L, Zhuang R, Yu P, Xu Z, Liu G et al (2020) The gut microbial metabolite trimethylamine N-oxide and hypertension risk: a systematic review and dose-response meta-analysis. Adv Nutr 11(1):66\u201376","journal-title":"Adv Nutr"},{"issue":"12","key":"10530_CR130","first-page":"1700","volume":"30","author":"M Ufnal","year":"2014","unstructured":"Ufnal M, Jazwiec R, Dadlez M, Drapala A, Sikora M, Skrzypecki J (2014) Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. Can J Cardiol 30(12):1700\u20131705","journal-title":"Can J Cardiol"},{"key":"10530_CR131","doi-asserted-by":"crossref","unstructured":"Konop M, Jaworska K, Bielinska K, Bielak-Zmijewska A, Mosieniak G, Sikora E, et al. Abstract P3021: trimethylamine but not trimethylamine N-oxide increases blood pressure in rats, affects viability of vascular smooth muscle cells and degrades protein structure. Hypertension. 2019;74(Suppl_1):AP3021-AP.","DOI":"10.1161\/hyp.74.suppl_1.P3021"},{"issue":"1","key":"10530_CR132","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/cber.186900201122","volume":"2","author":"C Scheibler","year":"1869","unstructured":"Scheibler C (1869) Ueber das Betain, eine im Safte der Zuckerr\u00fcben (Beta vulgaris) vorkommende Pflanzenbase. Ber Dtsch Chem Ges 2(1):292\u2013295","journal-title":"Ber Dtsch Chem Ges"},{"issue":"9","key":"10530_CR133","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.clinbiochem.2010.03.009","volume":"43","author":"M Lever","year":"2010","unstructured":"Lever M, Slow S (2010) The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem 43(9):732\u2013744","journal-title":"Clin Biochem"},{"issue":"9","key":"10530_CR134","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tplants.2008.06.007","volume":"13","author":"TH Chen","year":"2008","unstructured":"Chen TH, Murata N (2008) Glycinebetaine: an effective protectant against abiotic stress in plants. Trends Plant Sci 13(9):499\u2013505","journal-title":"Trends Plant Sci"},{"key":"10530_CR135","first-page":"1","volume-title":"Cellular osmolytes: from chaperoning protein folding to clinical perspectives","author":"P Chaudhuri","year":"2017","unstructured":"Chaudhuri P, Rashid N, Thapliyal C (2017) Osmolyte system and its biological significance. In: Rajendrakumar Singh L, Dar TA (eds) Cellular osmolytes: from chaperoning protein folding to clinical perspectives. Springer Singapore, Singapore, pp 1\u201334"},{"key":"10530_CR136","doi-asserted-by":"publisher","unstructured":"Preedy VR (2015) Betaine: chemistry, analysis, function and effects. The Royal Society of Chemistry, pp. P001-P004. https:\/\/doi.org\/10.1039\/9781782628446","DOI":"10.1039\/9781782628446"},{"issue":"1","key":"10530_CR137","doi-asserted-by":"publisher","first-page":"e0294926","DOI":"10.1371\/journal.pone.0294926","volume":"19","author":"I Mogilnicka","year":"2024","unstructured":"Mogilnicka I, Jaworska K, Koper M, Maksymiuk K, Szudzik M, Radkiewicz M et al (2024) Hypertensive rats show increased renal excretion and decreased tissue concentrations of glycine betaine, a protective osmolyte with diuretic properties. PLoS ONE 19(1):e0294926","journal-title":"PLoS ONE"},{"issue":"1","key":"10530_CR138","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0033-1360127","volume":"80","author":"YL Liu","year":"2014","unstructured":"Liu YL, Pan Y, Wang X, Fan CY, Zhu Q, Li JM et al (2014) Betaine reduces serum uric acid levels and improves kidney function in hyperuricemic mice. Planta Med 80(1):39\u201347","journal-title":"Planta Med"},{"key":"10530_CR139","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s11033-009-9508-4","volume":"37","author":"B Ganesan","year":"2010","unstructured":"Ganesan B, Buddhan S, Anandan R, Sivakumar R, AnbinEzhilan R (2010) Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. Mol Biol Rep 37:1319\u20131327","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10530_CR140","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1159\/000464117","volume":"41","author":"A Nemmar","year":"2017","unstructured":"Nemmar A, Al-Salam S, Beegam S, Yuvaraju P, Oulhaj A, Ali BH (2017) Water-pipe smoke exposure-induced circulatory disturbances in mice, and the influence of betaine supplementation thereon. Cell Physiol Biochem 41(3):1098\u20131112","journal-title":"Cell Physiol Biochem"},{"key":"10530_CR141","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00394-009-0003-4","volume":"48","author":"S Lv","year":"2009","unstructured":"Lv S, Fan R, Du Y, Hou M, Tang Z, Ling W et al (2009) Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice. Eur J Nutr 48:205\u2013212","journal-title":"Eur J Nutr"},{"issue":"1","key":"10530_CR142","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/clinchem\/hvaa224","volume":"67","author":"C Papandreou","year":"2021","unstructured":"Papandreou C, Bull\u00f3 M, Hern\u00e1ndez-Alonso P, Ruiz-Canela M, Li J, Guasch-Ferr\u00e9 M et al (2021) Choline metabolism and risk of atrial fibrillation and heart failure in the PREDIMED study. Clin Chem 67(1):288\u2013297","journal-title":"Clin Chem"},{"issue":"2","key":"10530_CR143","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","volume":"21","author":"WHW Tang","year":"2015","unstructured":"Tang WHW, Wang Z, Shrestha K, Borowski AG, Wu Y, Troughton RW et al (2015) Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J Card Fail 21(2):91\u201396","journal-title":"J Card Fail"},{"key":"10530_CR144","doi-asserted-by":"crossref","unstructured":"Lever M, George PM, Slow S, Bellamy D, Young JM, Ho M, et al. Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: an observational study. PloS one. 2014;9(12):e114969-e.","DOI":"10.1371\/journal.pone.0114969"},{"issue":"10","key":"10530_CR145","doi-asserted-by":"publisher","first-page":"e14041","DOI":"10.1111\/eci.14041","volume":"53","author":"Q Yang","year":"2023","unstructured":"Yang Q, Han H, Sun Z, Liu L, Zheng X, Meng Z et al (2023) Association of choline and betaine with the risk of cardiovascular disease and all-cause mortality: meta-analysis. European Journal of Clinical Investigation. 53(10):e14041","journal-title":"European Journal of Clinical Investigation."},{"issue":"5","key":"10530_CR146","doi-asserted-by":"publisher","first-page":"e37883","DOI":"10.1371\/journal.pone.0037883","volume":"7","author":"M Lever","year":"2012","unstructured":"Lever M, George PM, Elmslie JL, Atkinson W, Slow S, Molyneux SL et al (2012) Betaine and secondary events in an acute coronary syndrome cohort. PLoS ONE 7(5):e37883","journal-title":"PLoS ONE"},{"issue":"5","key":"10530_CR147","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ajcn\/76.5.961","volume":"76","author":"U Schwab","year":"2002","unstructured":"Schwab U, T\u00f6rr\u00f6nen A, Toppinen L, Alfthan G, Saarinen M, Aro A et al (2002) Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr 76(5):961\u2013967","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10530_CR148","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/jn\/138.5.914","volume":"138","author":"SV Konstantinova","year":"2008","unstructured":"Konstantinova SV, Tell GS, Vollset SE, Nyg\u00e5rd O, Bleie \u00d8, Ueland PM (2008) Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 138(5):914\u2013920","journal-title":"J Nutr"},{"issue":"2","key":"10530_CR149","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jch.13190","volume":"20","author":"L Wang","year":"2018","unstructured":"Wang L, Zhao M, Liu W, Li X, Chu H, Bai Y et al (2018) Association of betaine with blood pressure in dialysis patients. J Clin Hypertens (Greenwich) 20(2):388\u2013393","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"10530_CR150","first-page":"717","volume":"25","author":"PF Abaurre","year":"1992","unstructured":"Abaurre PF, Stefanon I, Mill JG, Vassallo DV (1992) Electromechanical effects of urea on the isolated rat heart. Braz J Med Biol Res 25(7):717\u2013726","journal-title":"Braz J Med Biol Res"},{"key":"10530_CR151","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1681\/ASN.2006101108","volume":"18","author":"R Fenton","year":"2007","unstructured":"Fenton R, Knepper M (2007) Fenton RA, Knepper MAUrea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol 18:679\u201388","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10530_CR152","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00726-012-1314-y","volume":"43","author":"X Han","year":"2012","unstructured":"Han X, Chesney RW (2012) The role of taurine in renal disorders. Amino Acids 43(6):2249\u20132263","journal-title":"Amino Acids"},{"issue":"5","key":"10530_CR153","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1046\/j.1523-1755.2002.00317.x","volume":"61","author":"MS Mozaffari","year":"2002","unstructured":"Mozaffari MS, Schaffer SW (2002) Chronic taurine treatment ameliorates reduction in saline-induced diuresis and natriuresis. Kidney Int 61(5):1750\u20131759","journal-title":"Kidney Int"},{"key":"10530_CR154","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-4899-1471-2_21","volume-title":"Taurine in Health and Disease","author":"MJ Meldrum","year":"1994","unstructured":"Meldrum MJ, Tu R, Patterson T, Dawson R, Petty T (1994) The effect of taurine on blood pressure, and urinary sodium, potassium and calcium excretion. In: Huxtable RJ, Michalk D (eds) Taurine in Health and Disease. Springer US, Boston, pp 207\u2013215"},{"issue":"2","key":"10530_CR155","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.ki.5001503","volume":"70","author":"MS Mozaffari","year":"2006","unstructured":"Mozaffari MS, Patel C, Abdelsayed R, Schaffer SW (2006) Accelerated NaCl-induced hypertension in taurine-deficient rat: role of renal function. Kidney Int 70(2):329\u2013337","journal-title":"Kidney Int"},{"issue":"18","key":"10530_CR156","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WHW Tang","year":"2014","unstructured":"Tang WHW, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM et al (2014) Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol 64(18):1908\u20131914","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10530_CR157","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/advances\/nmab010","volume":"12","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Guo M, Fang X, Teng F, Tan X, Li X et al (2021) Gut microbiota-derived trimethylamine N-oxide and kidney function: a systematic review and meta-analysis. Adv Nutr 12(4):1286\u20131304","journal-title":"Adv Nutr"},{"key":"10530_CR158","doi-asserted-by":"publisher","first-page":"1488264","DOI":"10.3389\/fcimb.2025.1488264","volume":"15","author":"J-Q Su","year":"2025","unstructured":"Su J-Q, Wu X-Q, Wang Q, Xie B-Y, Xiao C-Y, Su H-Y et al (2025) The microbial metabolite trimethylamine N-oxide and the kidney diseases. Front Cell Infection Microbiol 15:1488264","journal-title":"Front Cell Infection Microbiol"},{"issue":"3","key":"10530_CR159","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13668-022-00426-z","volume":"11","author":"L Alvarenga","year":"2022","unstructured":"Alvarenga L, Ferreira MS, Kemp JA, Mafra D (2022) The role of betaine in patients with chronic kidney disease: a narrative review. Curr Nutr Rep 11(3):395\u2013406","journal-title":"Curr Nutr Rep"},{"issue":"6","key":"10530_CR160","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00360-018-1164-3","volume":"188","author":"CM Nawata","year":"2018","unstructured":"Nawata CM, Pannabecker TL (2018) Mammalian urine concentration: a review of renal medullary architecture and membrane transporters. J Comp Physiol B 188(6):899\u2013918","journal-title":"J Comp Physiol B"},{"key":"10530_CR161","doi-asserted-by":"publisher","unstructured":"Anas M-KI, Lee MB, Zhou C, Hammer M-A, Slow S, Karmouch J, et al. SIT1 is a betaine\/proline transporter that is activated in mouse eggs after fertilization and functions until the 2-cell stage. 2008. https:\/\/doi.org\/10.1242\/dev.026575","DOI":"10.1242\/dev.026575"},{"issue":"1\u20132","key":"10530_CR162","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1748-1716.2006.01573.x","volume":"187","author":"X Han","year":"2006","unstructured":"Han X, Patters A, Jones D, Zelikovic I, Chesney R (2006) The taurine transporter: mechanisms of regulation. Acta Physiol 187(1\u20132):61\u201373","journal-title":"Acta Physiol"},{"issue":"5","key":"10530_CR163","doi-asserted-by":"publisher","first-page":"F1336","DOI":"10.1152\/ajprenal.90228.2008","volume":"295","author":"NW Blessing","year":"2008","unstructured":"Blessing NW, Blount MA, Sands JM, Martin CF, Klein JD (2008) Urea transporters UT-A1 and UT-A3 accumulate in the plasma membrane in response to increased hypertonicity. Am J Physiol Renal Physiol 295(5):F1336\u2013F1341","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10530_CR164","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1681\/ASN.V11111980","volume":"11","author":"SM Bagnasco","year":"2000","unstructured":"Bagnasco SM, Peng T, Nakayama Y, Sands JM (2000) Differential expression of individual UT-A urea transporter isoforms in rat kidney. J Am Soc Nephrol 11(11):1980\u20131986","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10530_CR165","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1681\/ASN.2006101108","volume":"18","author":"RA Fenton","year":"2007","unstructured":"Fenton RA, Knepper MA (2007) Urea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol 18(3):679\u2013688","journal-title":"J Am Soc Nephrol"},{"key":"10530_CR166","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejmech.2019.03.060","volume":"172","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Li M, Li B, Zhang S, Su A, Xing Y et al (2019) Discovery and optimization of thienopyridine derivatives as novel urea transporter inhibitors. Eur J Med Chem 172:131\u2013142","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10530_CR167","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ki.2013.94","volume":"83","author":"MA Knepper","year":"2013","unstructured":"Knepper MA, Miranda CA (2013) Urea channel inhibitors: a new functional class of aquaretics. Kidney Int 83(6):991\u2013993","journal-title":"Kidney Int"},{"issue":"1","key":"10530_CR168","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41401-019-0245-5","volume":"41","author":"M Li","year":"2020","unstructured":"Li M, Zhao Y, Zhang S, Xu Y, Wang SY, Li BW et al (2020) A thienopyridine, CB-20, exerts diuretic activity by inhibiting urea transporters. Acta Pharmacol Sin 41(1):65\u201372","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10530_CR169","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1021\/acs.molpharmaceut.6b00937","volume":"14","author":"WA Teft","year":"2017","unstructured":"Teft WA, Morse BL, Leake BF, Wilson A, Mansell SE, Hegele RA et al (2017) Identification and characterization of trimethylamine-N-oxide uptake and efflux transporters. Mol Pharm 14(1):310\u2013318","journal-title":"Mol Pharm"},{"issue":"9","key":"10530_CR170","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.xphs.2017.04.067","volume":"106","author":"T Miyake","year":"2017","unstructured":"Miyake T, Mizuno T, Mochizuki T, Kimura M, Matsuki S, Irie S et al (2017) Involvement of organic cation transporters in the kinetics of trimethylamine N-oxide. J Pharm Sci 106(9):2542\u20132550","journal-title":"J Pharm Sci"},{"issue":"1","key":"10530_CR171","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1038\/s41598-018-25139-8","volume":"8","author":"A Gessner","year":"2018","unstructured":"Gessner A, K\u00f6nig J, Fromm MF (2018) Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO). Sci Rep 8(1):6659","journal-title":"Sci Rep"},{"issue":"1","key":"10530_CR172","doi-asserted-by":"publisher","first-page":"e0297474","DOI":"10.1371\/journal.pone.0297474","volume":"19","author":"KM Maksymiuk","year":"2024","unstructured":"Maksymiuk KM, Szudzik M, Samborowska E, Chabowski D, Konop M, Ufnal M (2024) Mice, rats, and guinea pigs differ in FMOs expression and tissue concentration of TMAO, a gut bacteria-derived biomarker of cardiovascular and metabolic diseases. PLoS ONE 19(1):e0297474","journal-title":"PLoS ONE"},{"key":"10530_CR173","doi-asserted-by":"publisher","first-page":"1340166","DOI":"10.3389\/fphys.2024.1340166","volume":"15","author":"M Gawry\u015b-Kopczy\u0144ska","year":"2024","unstructured":"Gawry\u015b-Kopczy\u0144ska M, Szudzik M, Samborowska E, Konop M, Chabowski D, Onyszkiewicz M et al (2024) Spontaneously hypertensive rats exhibit increased liver flavin monooxygenase expression and elevated plasma TMAO levels compared to normotensive and Ang II-dependent hypertensive rats. Front Physiol 15:1340166","journal-title":"Front Physiol"},{"key":"10530_CR174","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/978-0-387-92271-3_122","volume-title":"Handbook of behavior, food and nutrition","author":"Z-H Zhu","year":"2011","unstructured":"Zhu Z-H, Wang B-R, McTaggart JS, Xiong L-Z (2011) Neuronal circuits and neuroendocrine responses involved in dehydration induced by water restriction\/deprivation. In: Preedy VR, Watson RR, Martin CR (eds) Handbook of behavior, food and nutrition. Springer New York, New York, pp 1873\u201395"},{"issue":"6","key":"10530_CR175","first-page":"e40725","volume":"15","author":"AK Kanugula","year":"2023","unstructured":"Kanugula AK, Kaur J, Batra J, Ankireddypalli AR, Velagapudi R (2023) Renin-angiotensin system: updated understanding and role in physiological and pathophysiological states. Cureus 15(6):e40725","journal-title":"Cureus"},{"issue":"7","key":"10530_CR176","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/nu10070907","volume":"10","author":"H Wang","year":"2018","unstructured":"Wang H, Li S, Fang S, Yang X, Feng J (2018) Betaine improves intestinal functions by enhancing digestive enzymes, ameliorating intestinal morphology, and enriching intestinal microbiota in high-salt stressed rats. Nutrients 10(7):907","journal-title":"Nutrients"},{"issue":"2","key":"10530_CR177","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0301-0082(99)00071-4","volume":"62","author":"N Hussy","year":"2000","unstructured":"Hussy N, Deleuze C, Desarm\u00e9nien MG, Moos FC (2000) Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog Neurobiol 62(2):113\u2013134","journal-title":"Prog Neurobiol"},{"key":"10530_CR178","doi-asserted-by":"publisher","first-page":"e57028","DOI":"10.7554\/eLife.57028","volume":"9","author":"M Gawrys-Kopczynska","year":"2020","unstructured":"Gawrys-Kopczynska M, Konop M, Maksymiuk K, Kraszewska K, Derzsi L, Sozanski K et al (2020) TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats. Elife 9:e57028","journal-title":"Elife"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10530-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10530-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10530-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:56:38Z","timestamp":1757184998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10530-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":178,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["10530"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10530-1","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"20 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}